Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

China flag China · Delayed Price · Currency is CNY
45.30
+2.55 (5.96%)
At close: Feb 27, 2026
Market Cap4.91B +60.1%
Revenue (ttm)435.52M -0.5%
Net Income52.06M +3.8%
EPS0.48 +4.2%
Shares Out108.29M
PE Ratio93.67
Forward PEn/a
Dividend0.20 (0.47%)
Ex-Dividend DateMay 20, 2025
Volume7,674,201
Average Volume5,611,590
Open42.74
Previous Close42.75
Day's Range41.80 - 45.87
52-Week Range24.60 - 45.30
Beta-1.32
RSI87.03
Earnings DateApr 16, 2026

About SHE:301281

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofe... [Read more]

Sector Healthcare
Founded 2004
Employees 696
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301281
Full Company Profile

Financial Performance

In 2024, SHE:301281's revenue was 463.72 million, an increase of 3.60% compared to the previous year's 447.58 million. Earnings were 60.27 million, a decrease of -21.76%.

Financial Statements